FPS Pharma Changes Name to Capha Pharmaceuticals Inc.
Kyle J. Remenda Appointed President & COO
/EINPresswire.com/ -- WEST KELOWNA, BC--(Marketwired - January 16, 2017) - FPS PHARMA INC. (the "Company") is pleased to announce that effective today, the Company changed its name to Capha Pharmaceuticals Inc. The Company is also pleased to announce that Kyle J. Remenda has been appointed President and Chief Operating Officer. James R. Brown will remain Chairman and Chief Executive Officer.
ON BEHALF OF THE BOARD OF DIRECTORS
"James R. Brown"
James R. Brown
Chairman
James R. Brown
778-754-3000
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
